The human neuronal apoptosis inhibitory protein (NAIP) gene has been discovered as a candidate gene for spinal muscular atrophy, a genetic disorder characterized by motor neuron loss in the spinal cord. The telomeric NAIP gene on human chromosome 5 is deleted together with survival motor neurons (SMN) in many cases of the most severe forms of the disorder. NAIP, c-IAP1 (inhibitor of apoptosis-1), c-IAP2, X-IAP, survivin and Apollon comprise the mammalian inhibitors of the apoptosis family and contain an N-terminal domain with 1-3 imperfect repeats of an ∼65 amino acids domain named the baculovirus IAP repeat (BIR) motif. We identified six NAIP genes in the mouse genome which were found to be expressed in a broad range of tissues. Furthermore, we have investigated the effects of NAIP in the rat pheochromocytoma PC12 cell line. These cells differentiate in the presence of nerve growth factor (NGF) into cells that resemble sympathetic neurons. We observed that NAIP overexpression impaired NGF-induced neurite outgrowth. The BIR motifs of NAIP (residues 1-345) were not required for this effect. However, the BIR domains of NAIP were essential to prevent apoptosis in PC12 cells after NGF deprivation or TNF-α receptor stimulation. Expression of full-length but not BIR-deleted-NAIP protects against cell death. This correlates with reduced activity of the cell death effector protease, caspase-3, in lysates of NAIP-PC12 cells, as measured by cleavage of the fluorogenic tetrapeptide substrate Asp-Glu-Val-Asp. Thus, unregulation of cellular differentiation and/or caspase suppression may contribute to motoneuron dysfunction and cell death in spinal muscular atrophy where NAIP is mutated.
INTRODUCTION
Proximal childhood spinal muscular atrophy (SMA) is a common autosomal recessive disorder, which is characterized by the degeneration of motor neurons in the spinal cord and brain stem nuclei. Several types of the disorder have been defined which vary with onset and clinical severity (1) . The most severe form (type I SMA or Werdnig-Hoffmann disease) starts before the first 6 months of life. Death from respiratory failure usually occurs within the first 2 years of life. The intermediate form, SMA type II, starts later and the affected children are able to sit although they cannot stand or walk unaided. The life expectancy is determined by the degree of respiratory muscle weakness. Type III patients (Kugelberg-Welander disease) have proximal muscle weakness, starting after 18 months of life, but they can walk unaided. SMA occurs in ∼1 in 10 000 live births and has a carrier frequency of 1 in 50 (2) . All three forms of proximal SMA have been mapped to chromosome 5q13 (3) . The human SMA locus is a highly complex genetic region containing both genetic markers and transcribed sequences in multiple copies. This complexity is also reflected by the genomic structure of the two candidate genes associated with SMA, survival motor neurons (SMN) and neuronal apoptosis inhibitory protein (NAIP), which were identified by positional cloning (4, 5) . SMN is present as two nearly identical copies each located within a duplicated 500 kb region (4) . The telomeric copy of SMN (SMN T or SMN1) is deleted in 95% of SMA cases. The centromeric SMN copy (SMN C or SMN2) can be distinguished from SMN1 only by five base pair changes. Only one of these exchanges affects SMN protein structure. A C→T transition at codon 280 of SMN2 is responsible for alternative splicing of exon 7 leading to a gene product which preferentially lacks the exon 7-encoded amino acids (6, 7) .
Some correlation has been observed between SMN protein levels and disease severity (8, 9) . Nevertheless, the potential existence of a closely linked SMA modifying gene remains a plausible explanation to account for the wide variation in disease severity seen in SMA patients. NAIP is such a candidate for a modifying gene, because it is deleted in <50% of type I but only in 10-20% of type II and III patients (5) . Only one complete NAIP gene is located on human chromosome 5 and is deleted in a majority of type I SMA patients. A truncated + To whom correspondence should be addressed. Tel: +49 931 201 3849; Fax: +49 931 201 3835; Email: goetz@mail.uni-wuerzburg.de NAIP gene lacking the first two coding exons is closely associated with the centromeric SMN2 gene but does not play a role in SMA (5) .
NAIP belongs to the inhibitor of apoptosis (IAP) family of anti-apoptotic proteins which were first identified in baculoviruses (10) . Subsequently, homologous genes were identified in Drosophila and mammals (11) . Their gene products function as suppressors of apoptosis in a broad variety of cultured cell types (12, 13) . c-IAP1 and c-IAP2 were found in protein complexes together with tumour necrosis factor receptorassociated factor-1 (TRAF-1) and TRAF-2 heterodimers (14, 15) . More recently, X-IAP, c-IAP1, c-IAP2 and survivin (16) (17) (18) (19) (20) but not NAIP (17) have been found to be direct inhibitors of specific caspases.
The IAP proteins contain an N-terminal domain with 1-3 repeats of an ∼65 amino acid motif, termed the baculovirus IAP repeat (BIR), and in some cases a C-terminal RING finger domain (21) . The BIR domain is found in IAP proteins either in one [in survivin and Apollon (22, 23) ] or in multiple copies and is required for interactions with TRAFs and the inhibition of caspases. The anti-apoptotic effects of IAPs also depend on these domains (14, 17, 19, 24) . The structural homology between NAIP and the IAPs is restricted to the BIR motif (36-38% identity in the mouse). Despite this significant homology in the functionally important BIR domains, NAIP did not interact with TRAFs and apparently did not inhibit caspases in in vitro studies using bacterially expressed protein (17) . In this respect, and because of its much larger size, NAIP differs from the classical IAPs. Therefore, its relation to the prototypical IAPs is unclear. Nevertheless, NAIP shows anti-apoptotic activity similar to other IAPs on overexpression in cell lines and neuronal cells (25, 26) .
An important facet of the IAPs is their regulation on various external stimuli. Inflammatory cytokines such as tumour necrosis factor-α (TNF-α) induce the expression of c-IAP1 and c-IAP2 in several cell types (27, 28) . X-IAP is up-regulated by vascular endothelial growth factor in vascular endothelial cells (29) . Apparently, a reciprocal interdependence of c-IAP and nuclear factor kappa B (NF-κB) exists in as much as NF-κB is needed for the induction of c-IAP2 and c-IAP2 overexpression does activate NF-κB (27) . This coordination appears to be essential to block caspase-8 activation and apoptosis (30) . Nerve growth factor (NGF) is a potent inducer of inhibitor of T cell apoptosis (ITA), the chick homologue of c-IAP2 (31) . Embryonic sensory and sympathetic neurons cultured for several hours in the presence of NGF show a >20-fold up-regulation of ITA expression (31) . Overexpression of full-length ITA but not of a truncated protein that lacks the BIR domains supports survival of these neurons even in the absence of NGF (31) . This finding suggests that the neurotrophic factor-mediated survival of primary sensory and sympathetic neurons and probably also motor neurons, involves expression of members of the IAP/NAIP family.
Neuronal survival is promoted by specific growth factors, for example neurotrophins which act on distinct neuronal populations by binding to specific cell surface receptors (32, 33) . Removal of these survival factors modifies signaling pathways that eventually lead to apoptosis (34, 35) . The cell line PC12 expresses TrkA as well as the pan-neurotrophin receptor p75 and thus can respond to the neurotrophic factor NGF. Therefore, these cells are widely used as a model for analysis of neurotrophin signal transduction, for differentiation and regulation of cell survival (36) . After binding of NGF to the cell surface tyrosine kinase receptor TrkA, downstream signaling cascades are activated, most notably the Ras/MAPK (mitogen-activated protein kinase) and the lipid kinase phosphoinositide 3-OH kinase/AKT pathways. These molecules are involved in promoting neurite outgrowth in response to NGF (37) . Once NGF has differentiated these cells, withdrawal of this factor causes morphological changes characteristic of apoptosis, including retraction of neurites and condensation of nuclei (38) . Apoptosis of PC12 cells after NGF withdrawal correlates with increased caspase-3 activity (39) . Thus, caspase activation in PC12 cells is analogous to that seen in primary cultured neurons after neurotrophin withdrawal or during naturally occurring cell death (40) .
In the study reported here we have investigated how NAIP interferes with NGF-mediated signaling in PC12 cells. We observe that NAIP overexpression impaired NGF-induced neurite outgrowth. The BIR motifs of NAIP are not required for this effect; however, they are essential for inhibition of apoptosis after NGF deprivation or TNF-α exposure. Expression of full-length but not BIR-deleted NAIP protects against cell death. This effect correlates with reduced activity of the cell death effector protease, caspase-3, in cell lysates of NAIPoverexpressing PC12 cells.
RESULTS

Characterization of multiple murine homologues of NAIP
A previous study has shown that one complete copy of the NAIP gene and a second truncated copy exist on human chromosome 5 with the complete telomeric NAIP being deleted in a majority of type I SMA patients (5) . The centromeric truncated NAIP gene lacks the first two coding exons and apparently does not play a role in SMA (5) . A DNA fragment spanning the first coding exon of NAIP was amplified by PCR from human genomic DNA and used as a probe for isolation of mouse strain 129/SvJ genomic λ phage and bacterial artificial chromosome (BAC) clones. A detailed restriction enzyme analysis of <20 λ phage clones and 15 BAC clones containing the genomic NAIP sequences from mouse strain 129/SvJ revealed the existence of up to six differently sized fragments, depending on the enzyme used, that hybridized with the exon 1 probe (Fig. 1 ). In line with this finding, we found that all of the bands represented in the different genomic clones were also detectable by genomic Southern blot analysis, thereby providing direct evidence for the existence of multiple NAIP alleles (data not shown). This finding confirms other previously published studies (41) (42) (43) .
Hybridization with the probe spanning the first coding exon also revealed that some BAC clones contained two NAIP genes. For example, clones 227n6 and 143h14 showed two different hybridizing fragments (Fig. 1A) . Thus the NAIP genes are closely linked in the mouse genome as reported previously by independent laboratories (41) (42) (43) . Hybridization of BAC clones with a probe specific for the ninth coding exon also revealed multiple fragments of different sizes (data not shown). Only one BAC clone (227n6) which contained the mouse SMN gene demonstrated a physical linkage between SMN and NAIP (data not shown). Sequence analysis of EcoRI restriction fragments containing the six different NAIP alleles verified that they contained the first coding exon of NAIP and adjacent exons (Fig. 1B) .
Developmental expression and tissue distribution of the mRNA for six NAIP alleles in the mouse
To investigate which of the different NAIP alleles are expressed in neuronal and non-neuronal tissues of the mouse, we have developed specific tests for semiquantitative evaluation of expression of these different NAIP genes employing RT-PCR. Allele-specific forward primers located in the first coding exon and antisense primers located in the second or third coding exons were deduced from the sequences of the individual NAIP genes (Fig. 1B ). They were used to monitor the presence of NAIP transcripts in the developing spinal cord in comparison with various neuronal and non-neuronal tissues of the adult mouse. In order to test the specificity of the primer pairs for the individual NAIP genes, we performed PCR under the same conditions with each primer pair using either genomic NAIP clones or cDNA plasmids (for NAIP-2 and NAIP-4) as templates ( Fig. 2A) . The length of the amplification products was similar for all NAIP isoforms ( Fig. 2A ) in order to avoid problems caused by insufficient PCR due to large introns in the template. All NAIPs with the exception of NAIP-3 and NAIP-6 were found to be widely expressed in the tissues and organs analysed (Fig. 2B) . Expression of NAIP-1, -2 and -4 was relatively weak in spinal cord at embryonic day 14, but increased during subsequent stages of development.
Establishment of NAIP-overexpressing PC12 cell lines
To explore the effects of NAIPs in neuronal cells, we have overexpressed NAIP-2 in PC12 cells. This cell line is an established model for investigation of neurotrophic factor-mediated signaling pathways, thus allowing the analysis of the role of NAIP in the context of such signaling pathways which regulate neuronal survival and neurite outgrowth (36) . A full-length cDNA corresponding to the NAIP-2 gene was isolated from a mouse spleen cDNA library; it encodes a protein of 1444 amino acids with three BIR domains at the N-terminus (Fig.  3A) . The BIR domains are the most conspicuous motif that has been identified in NAIP. In an attempt to clarify the functional role of these domains in NAIP, we have constructed an expression plasmid encoding a truncated NAIP-2 protein devoid of residues 2-344 corresponding to the region containing the three BIR motifs (BIR-del-NAIP) (Fig. 3A) .
Several NAIP-and BIR-del-NAIP-overexpressing PC12 cell clones were established after transfection of PC12 cells with the NAIP cDNA expression vector and antibiotic selection. We confirmed expression of NAIP by RT-PCR (data not shown) and western blot analysis. NAIP RNA or protein expression was not observed in clones transfected with empty vector (Fig. 3B ). The overexpression of NAIP isoforms of the predicted size was monitored using an antibody directed against part of the NAIP sequence which is highly preserved between all NAIP isoforms (see Materials and Methods). No NAIP immunoreactivity was detectable in vector-transfected cells demonstrating the specificity of our antibody (Fig. 3B) . This finding also indicates that NAIP expression in normal PC12 cells is below levels that can be detected by western blot analysis.
Overexpression of NAIP impairs neurite outgrowth in PC12 cells
In the presence of NGF, PC12 cells grow neurites within 24 h. PC12 clones overexpressing NAIP or BIR-del-NAIP show a severe impairment of neurite outgrowth after NGF addition ( Figs 3C and 4) . Analysis of two PC12 clones transfected with an empty expression plasmid and two clones overexpressing Bcl-2 revealed that they were not impaired in differentiation after NGF addition (data not shown) indicating that neither the selection procedure, nor the overexpression of (anti-apoptotic) proteins, interferes with differentiation in PC12 cells. A quantification of neurite outgrowth over a culture period of 5 days is shown in Figure 4C . At longer incubation times with NGF (≥3 days), few and short neurites became detectable. This indicates that the inhibition of the differentiation program and signaling pathways by NAIP is not absolute and probably depends on the levels of NAIP overexpression.
Rescue of neurite outgrowth in NAIP-PC12 cells
In order to test whether the inhibition of neurite outgrowth in NAIP-PC12 cells occurs by specific interference with NGFactivated signaling pathways or as an unspecific or toxic effect, we have analysed the effect of elevated cAMP levels which is known to promote neurite outgrowth in PC12 cells in an NGFindependent fashion. The addition of forskolin stimulated neurite outgrowth in NAIP-2-overexpressing PC12 cells within 24 h at a similar extent as in wild-type PC12 cells ( Fig. 5A and B) . Longer observation times were not possible because PC12 cells detach from the culture dish when continuously grown with forskolin (data not shown). We further investigated whether the human serine/threonine kinase Cot, which is a direct activator of the kinase MEK and thus can induce differentiation of PC12 cells (44) , could restore neurite outgrowth in NAIP-PC12 cells. Expression of an activated form of the human serine/threonine kinase Cot (44) in NAIP-PC12 cells completely restored neurite outgrowth ( Fig. 5C and  D) . Analysis of the magnitude of extracellular signal-related kinase (ERK) phosphorylation before and after stimulation with NGF in both wild-type and NAIP-PC12 cells revealed no significant differences (data not shown).
NAIP-PC12 cells are resistant to apoptosis after NGF deprivation and TNF-α receptor stimulation
Another characteristic NGF effect in PC12 cells is the suppression of apoptosis after withdrawal of serum or trophic support. PC12 cells maintained with NGF in the absence of serum for 4 days showed much lower rates of apoptosis than PC12 cells without NGF (38) . The analysis of nuclear condensation/ fragmentation characteristic of apoptosis in two independent clones each revealed that NAIP-PC12 and BIR-del-NAIP-PC12 cells cultured with NGF did not differ from wild-type PC12 cells (Fig. 6A) . When NGF was withdrawn from the cultures under serum-free conditions, apoptosis was increased in PC12 and BIR-del-NAIP-PC12 cell lines in an indistinguishable manner (Fig. 6A) . However, under the same culture conditions, NAIP-2-overexpressing PC12 cells appeared resistant to apoptosis. They survived to a similar extent to that of PC12 cells maintained with NGF during the whole culture period (Fig. 6A ). This finding shows that NAIP overexpression protects PC12 cells from apoptosis after NGF deprivation. Furthermore, it indicates that the BIR domains are instrumental for the anti-apoptotic activity of NAIP.
To address the possible anti-apoptotic function of NAIP in PC12 cells under a different regimen and in a different signaling cascade, we treated these cells with 500 U/ml TNF-α. Exposure to TNF-α causes massive apoptosis in normal PC12 cells (45) . NAIP-PC12 cells were protected from TNF-α-induced apoptosis (Fig. 6B) , whereas PC12 cells overexpressing the truncated NAIP-2 lacking the BIR domains were not (Fig. 6B) .
Reduced caspase-3 activity in NAIP-PC12 cells after NGF withdrawal and TNF-α receptor stimulation
Induction of apoptosis by withdrawal of trophic factors in primary neurons as well as PC12 cells involves activation of caspase-3 (39, 46, 47) . Depending on the stimulus, different initiator caspases are initially activated that subsequently cleave common effector caspases, such as caspase-3 (48, 49) . We therefore investigated whether the regulation of the activity of an effector caspase might be responsible for the anti-apoptotic effect of NAIP in PC12 cells. Whereas NGF deprivation primarily activates caspase-9, TNF-α exposure leads to activation of the initiator caspase-8. The fluorogenic substrate acetyl-Asp-Glu-Val-Asp-aminomethylcoumarin which mimics the cleavage site at which caspase-3-like caspases (caspase-3 and -7) cleave cellular substrates was used to detect protease activity in lysates of the different PC12 cell lines. PC12 cells or BIR-del-NAIP-PC12 cells showed a strong increase in caspase-3-like activity after deprivation of NGF consistent with the activation of caspases during apoptosis (Fig. 7A) . In contrast, cell lysates from NGF-deprived NAIP-PC12 cells showed no significant increase in fluorogenic substrate cleavage in comparison with lysates from cells maintained with NGF throughout the culture period (Fig. 7A) . This indicates that Asp-Glu-Val-Asp-specific caspases are not activated in NAIP-overexpressing PC12 cells. Furthermore, the increase in caspase-3 activity observable in cytosolic lysates prepared from PC12 cells after TNF-α treatment was blocked in NAIP-PC12 cells (Fig. 7B) .
DISCUSSION
Our data indicate that NAIP is a potent inhibitor of cell death and a regulator of neurite outgrowth in neuronal cells. These findings could be of relevance concerning a potential role of NAIP as a modifier gene in the pathogenesis of spinal muscular atrophy, a genetic disorder characterized by motor neuron loss and dysfunction (5) . NAIP antagonizes NGF-induced differentiation by causing a significant delay in neurite outgrowth (Figs 3 and 4) . The effect on neurite outgrowth in PC12 cells is observed by expression of either full-length NAIP-2 or a truncated NAIP lacking the BIR domains (Fig. 3) . Thus, the Nterminal BIR domains (residues 1-334) (Fig. 3A) are not involved in this function of NAIP. Our data further indicate that untransfected PC12 cells do not express NAIP at levels which can be detected by western blot analysis with our antibody (Fig. 3B) . Similarly, only low levels of NAIP mRNA expression can be detected in the nervous system of the developing and postnatal mouse. At embryonic day 14, when motor neurons grow out their axons, only very little NAIP is expressed in the spinal cord. NAIP expression levels increase when axon elongation stops during the first 3 weeks after birth. In the adult, much higher levels of NAIP-1, -2 and -4 can be detected than in embryonic and perinatal spinal cord, which would be compatible with a role of NAIPs in regulating the differentiation of motor neurons. This effect of NAIP in PC12 cells seems to be specific and does not reflect a potential general toxic effect caused by the overexpression, as forskolin addition or the expression of the MEK kinase Cot rescue neurite outgrowth in the PC12 clones overexpressing NAIP-2 (Fig. 5) . Thus, the antagonizing effect of NAIP on neurite outgrowth seems to be reversible and a potential target of other regulatory mechanisms.
The Ras/Raf/MAPkinase pathway has been shown to be instrumental for the actions of NGF in PC12 cells (50) (51) (52) . On NGF addition, a long-lasting phosphorylation of ERKs is observed. However, NAIP overexpression does not change the activation of ERKs by NGF. Thus, the mechanism behind the retardation of neurite outgrowth is independent of ERK phosphorylation. Signaling through the Ras/Raf/MAPK pathway is subject to extensive modulation by other intersecting cascades which act in a cell type-specific fashion. Recently, Rap1 has been shown to act as a regulator of the activation of ERK in neuronal cell lines (53) . It will be interesting to investigate how NAIP interferes with such pathways and whether these or other signaling cascades are altered in motor neurons in the spinal cord of SMA patients.
The second effect of NAIP that we observed is the suppression of apoptosis after NGF withdrawal in differentiated PC12 cells or after treatment with the inflammatory cytokine TNF-α (Fig. 6) . The anti-apoptotic activity of NAIP requires the presence of the BIR domain, thus underscoring the importance of this structural motif for inhibition of apoptosis. Expression of a truncated NAIP protein lacking the BIR domains showed no protection from apoptosis. Thus, various domains of the NAIP protein differentially influence cellular responses of PC12 cells after stimulation with NGF and NGF withdrawal.
To address the mechanism behind the inhibition of apoptosis on NGF deprivation in NAIP-PC12 cells, we compared the level of caspase-3-like activities in control and in NAIP-overexpressing PC12 cells by using a specific tetrapeptide substrate (54) . During apoptosis, the initiator caspase-8 and -9 are activated by TNF-α exposure or NGF withdrawal, respectively (48, 49) . Subsequently, effector caspases such as caspase-3 are cleaved, pointing towards the operation of a caspase cascade (48, 49) . Caspase-3 is the main executor of apoptosis in neuronal cells and has been shown to be activated in PC12 cells after NGF deprivation (39) . Similarly, at least in amyotrophic lateral sclerosis, activation of caspase-3 has been observed in degenerating motor neurons (55) . Procaspase-3 is also a physiological target of caspase-8, which is activated by TNF-α signaling (56) . Inhibition of caspase-3-like activity was observed in lysates of NAIP-PC12 cells cultured in the absence of NGF or in the presence of TNF-α (Fig. 7) . Removal of the BIR domains abolished this inhibitory effect indicating that NAIP, as previously shown for other IAPs, can inhibit caspases through the BIR domains.
Our data on NAIP are in line with studies on other members of the IAP family showing an absence of active caspase-3 in cell lysates after apoptosis induction under several regimes: X-IAP, IAP1, IAP2 and survivin did inhibit caspase-3 and -7 (16, 17, 24) . Moreover, direct binding of IAPs to these caspases has been observed (16, 17) . On the other hand, caspase-1, -6 and -8 were not inhibited and did not interact with these IAPs (16, 17) . In addition, it has been shown that X-IAP, IAP1 and IAP2 can bind and inhibit procaspase-9, thus preventing further cleavage when exposed to cytochrome c and Apaf-1 (20) . A previous report has shown that a bacterially expressed part of NAIP encompassing the BIR domains neither interacted with TRAF-1 to -6 nor inhibited the activity of caspase-1, -3, -6, -7 and -8 (17) . Whether these differences reflect more adequate folding in the milieu of the mammalian cell compared with bacteria, or a specific property of the entire NAIP protein containing both the N-terminal BIR domains and additional C-terminal domains, remains to be determined.
The results of our study suggest that NAIP may exert effects on differentiation and survival of neurons including motor neurons, which are primarily affected in patients with SMA. The demonstration that all alleles of NAIP are strictly regulated during mouse development, with the lowest levels being detectable when dendritic and axonal outgrowth occur, suggests that NAIP could play a physiological role in the regulation of neurite elongation. These results are not contradictory to the observation that mice lacking the NAIP-1 gene apparently show normal development of motor neurons (57) , given that the expression of NAIP-1 in the developing spinal cord is low. Consequently, its absence may be compensated by the other NAIPs. However, in SMA type I patients the absence of the telomeric NAIP gene could have more pronounced effects on motor neuron differentiation and maintenance than in mouse models in which the existence of at least five NAIP genes expressed in spinal cord could give rise to multiple possibilities for compensation. This could explain the observation that type I SMA patients with a deletion of the telomeric NAIP gene show enhanced axonal pathology (58) .
MATERIALS AND METHODS
Isolation and sequencing of NAIP clones
A λ phage and a BAC library with genomic DNA from mouse strain 129/SvJ (Genome Systems, St Louis, MO) was screened with a radioactively labeled DNA probe spanning the first coding exon of NAIP using standard protocols. The DNA from positive clones was prepared using anion exchange chromatography (Qiagen Maxi kit; Qiagen, Hilden, Germany), digested with restriction enzymes and analysed by Southern blotting. EcoRI fragments from λ and BAC clones were subcloned into plasmids, and the fragments containing the first coding exon were subjected to DNA sequencing using an automated sequencer (Applied Biosystems, Foster City, CA). cDNA clones were obtained from a mouse spleen λ ZAPII library (Stratagene, Amsterdam, The Netherlands) by hybridization with a radioactively labeled DNA probe spanning the first coding exon of NAIP.
RT-PCR amplification
Tissues were lysed in Trizol (Life Technologies, Karlsruhe, Germany) and the RNA concentration determined photometrically using standard protocols. Twenty nanograms of total RNA was used for each RT-PCR reaction. Primer sequences were as follows: (i) NAIP-1, 5′-GTGTAGCTTGA-TCCTCTTTGGCAAT-3′ and 5′-CATCTCCTTCTTCCCAG-TTGG-3′, annealing temperature 64°C; (ii) NAIP-2, 5′-AAT-GGCAGCCCAGGGAGAAG-3′ and 5′-CATCTCCTTCTTC-CCAGTTGC-3′, annealing temperature 64°C; (iii) NAIP-3, 5′-ACTGAGGATGGAGATTCTGAGA-3′ and 5′-CATCTC-CTTCTTCCCAGTTGC-3′, annealing temperature 64°C; (iv) NAIP-4, 5′-GCTCGTTCGGGATGAATCT-3′ and 5′-CC-TCTGAGGATTTCTTACTTTGA-3′, annealing temperature 64°C; (v) NAIP-5, 5′-GGGTGGATGCATTTCAGGTA-3′ and 5′-CATCTCCTTCTTCCCAGTTGC-3′, annealing temperature 64°C; and (vi) NAIP-6, 5′-GGACATCACCACGTGCA-CTG-3′ and 5′-TGGGGAACCACTTGGCAT-3′, annealing temperature 67°C. After an initial denaturing step of 3 min at 94°C, the amplification of NAIP-1 to -5 and β-actin was carried out at 94°C for 30 s, 64°C for 1 min and 72°C for 1 min, for NAIP-6 at 94°C for 30 s, 67°C for 30 s and 72°C for 30 s. Forty-five cycles were employed for NAIP-1, -2 and -4, 40 cycles for NAIP-3 and -5, and 35 cycles for NAIP-6. As a control, cDNA from the same preparation was subjected to 35 cycles of PCR using primers for β-actin, 5′-GTGGGCCGCCCTAGGCAC-CAG-3′ and 5′-CTCTTTAATGTCACGCACGATTTC-3′. 
Cell culture and transfection experiments
The cell line PC12 was maintained in Dulbecco's modified Eagle's medium (DMEM/Glutamax; Life Technologies) with 10% horse serum and 5% fetal calf serum. For differentiation experiments, cells were plated at 2 × 10 4 /cm 2 on polyornithinecoated dishes the day before addition of NGF or forskolin (25 µM). PC12 cells were induced to differentiate by treatment with 50 ng/ml NGF in DMEM with 1% horse serum or without serum. After the cells could differentiate for 4 days with NGF in serum-free medium, apoptosis was induced by washing with NGF-free DMEM, followed by a 6-18 h incubation in NGF-free DMEM in the presence of the neutralizing anti-NGF monoclonal antibody 27/21 (Roche, Mannheim, Germany), as indicated in the figure legends. Control cells were washed with NGF-free medium and then incubated again with NGF-containing medium. Apoptosis in PC12 cells was also induced by exposure to 500 U/ml recombinant mouse TNF-α (Roche).
To establish PC12 lines stably overexpressing NAIP, expression plasmids were transfected using Superfect reagent (Qiagen) according to the manufacturer's protocol. G418 resistant colonies (∼100) were isolated from each transfection experiment. Clones stably expressing NAIP were identified by immunoblotting with an antiserum against NAIP (see below). The Cot kinase was overexpressed by retroviral infection as described previously by Hagemann et al. (44) .
NAIP constructs
The cDNA encoding mouse NAIP-2 was isolated from a spleen λ ZAPII library (Stratagene) and sequenced; it encodes a 1444 residue protein. The NAIP-encoding cDNA was ligated as an EcoRV-NotI fragment into the pcDNA3 expression vector (Invitrogen, Groningen, The Netherlands) with an Nterminal haemagglutinin epitope (HA) tag generated by standard PCR strategy to yield pcDNA-NAIP-2. A truncated construct (lacking the 344 N-terminal amino acids of the NAIP-2 protein containing the BIR domains) was generated by a PCR strategy using Pfu polymerase (Stratagene). The EcoRV-containing forward primer 5′-GCGCGGTACCAT-GGACTACAAAGATGACGACGACAAACTGCTTCGTG-TGAAAGGAGGAG-3′ (designed to contain a FLAG epitope tag) together with the AocI-containing reverse primer 5′-CCACACACATGACAGAGTTGAG-3′ was employed in this synthesis. After digestion of the PCR product at the EcoRV and AocI sites, the resulting ∼0.5 kb fragment was cloned into EcoRV/AocI-digested pcDNA-NAIP to yield pcDNA-Bir-del-NAIP. All constructs were fully sequenced to verify that they did not contain base exchanges caused by the PCR procedure.
Preparation and analysis of protein extracts
Cells treated with factors were washed with phosphate-buffered saline (PBS), resuspended in extraction buffer containing protease inhibitors and lysed as described by Harvey et al. (59) . For western immunoblots, 25 µg of protein extract was separated on SDS-polyacrylamide gels. Cells were washed two times with PBS and lysed in 1 ml of ice-cold lysis buffer (50 mM Tris pH 7.5, 250 mM NaCl, 10% glycerol, 1% Triton X-100, 0.01% 2-mercaptoethanol, 1 mM sodium vanadate, 1.5 mM MgCl 2 , 25 mM sodium fluoride, 0.01% leupeptin, 0.01% aprotinin, 2 mM pepstatin and 1 mM PMSF). Following transfer to nitrocellulose membranes, proteins were detected with either an anti-HA antibody (12CA5; Roche), an antiphospho-ERK (New England Biolabs, Schwalbach, Germany) and anti-ERK1/ERK2 antibody (SC-94) (Santa Cruz, Heidelberg, Germany). The antiserum against mouse NAIP was raised against a thioredoxin fusion protein encompassing amino acid residues 765-1108 of the NAIP-2 cDNA. This region is highly homologous among various NAIPs. These residues were present on a 1032 bp SacI fragment of the NAIP cDNA that was cloned into the expression vector pET32a (Novagen, Schwalbach, Germany). This plasmid was transformed into Escherichia coli BL and protein expression was induced with IPTG. The induced protein was purified by preparative SDS-PAGE and used for immunization of rabbits. Blots were developed using the appropriate horseradish peroxidase-coupled secondary antibodies and the ECL system (Amersham Pharmacia Biotech, Freiburg, Germany).
Cell death analysis
The number of apoptotic cells was assessed after staining the cells with Hoechst 33258 (2.5 µg/ml) after fixation with 4% paraformaldehyde. Nuclei that were fragmented or condensed were scored as apoptotic; in total, 300 nuclei/cells were counted for each group. Caspase-3 activity was measured by using a commercially available assay (CaspACE system; Promega, Heidelberg, Germany) which is based on the fluorogenic substrate Ac-DEVD-AMC (fluorochrome 7-amino-4-methylcoumarin). Proteolytic activity was measured after incubation of soluble cell extracts from the different PC12 clones. Lysates pre-treated with Ac-DEVD-CHO served as a negative control. Cleavage of Ac-DEVD-AMC was quantified with a fluorescence reader (Dynatech Fluorolite 1000; Dynex, Denkendorf, Germany).
